TB-500 has been developed to leverage the benefits of thymosin beta-4, focusing on enhancing tissue regeneration, reducing inflammation, and promoting overall recovery
Lv, X.-C., Guo, W.-L., Li, L., Yu, X.-D
For digestive issues, symptom scores, inflammatory markers, and potentially repeat endoscopy or permeability testing help assess response
Presented for research literature review only Davies MJ et al
References European Journal of Anaesthesiology Delta sleep-inducing peptide: discovery, structure, and pharmacological overview Neuroscience & Biobehavioral Reviews (PubMed) Delta-sleep-inducing peptide (DSIP): a review of sleep-promoting and neuromodulatory effects European Neurology (PubMed) Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia European Neurology (PubMed) DSIP in insomnia: timing and frequency of administration in clinical trials Tocris Bioscience Stability and storage guidelines for research peptides MedlinePlus (U.S